PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

46,012 stories, page 688 of 767

Advanced search
🇨🇭CDMObachem.comTier 2 · Direct publisher

Bachem inaugurates Building K in Bubendorf, strengthening large-scale production of modern APIs

Bachem PeptidesOriginal source
🇨🇭CDMOsiegfried.chTier 2 · Direct publisher

Siegfried obtains antitrust clearance for acquisition of three drug substances sites in the US and Australia

SiegfriedOriginal source
🇯🇵pharma_equipmentprodcms.ulvac.co.jpTier 2 · Direct publisher

Presentation at the 2026 IEEE 76th Electronic Components and Technology Conference (ECTC2026)

Ulvac (Pharma)Original source
🌍CROtrinetx.comTier 2 · Direct publisher

Powering Clinical Trial Innovation: How TriNetX Uses Databricks to Accelerate Drug Development

TriNetXOriginal source
🇺🇸Devicesviz.aiTier 1 · Company source

Viz.ai Announces Strategic Collaboration to Expand Access to AI-Powered Subdural Hemorrhage Care

Viz.aiOriginal source
🇫🇮Devicesaiforia.comTier 1 · Company source

Aiforia closes a deal with a private diagnostic laboratory in Italy

AiforiaOriginal source
🇺🇸CROinvestor.medpace.comTier 2 · Direct publisher

Medpace Holdings, Inc. Reports First Quarter 2026 Results

MedpaceOriginal source
🇺🇰Researchstemcells.cam.ac.ukTier 2 · Direct publisher

Damage to brain’s white matter may play key role in neurodegenerative disease, and could be target for future treatments

Cambridge Stem Cell InstituteOriginal source
🇺🇸Devicesbtig.comTier 1 · Company source

BTIG Expands its Mortgage and Real Estate Franchise

BTIGOriginal source
🌍Researchunityhealth.toTier 2 · Direct publisher

Toronto academic hospitals deepen climate leadership in second annual sustainability report

St. Michael's Hospital (Toronto)Original source
🇫🇷Researchchu-lyon.frTier 2 · Direct publisher

Tonic, le magazine des HCL : découvrez le n°205

Hospices Civils de LyonOriginal source
🇫🇷Researchchu-lyon.frTier 2 · Direct publisher

Découvrez le magazine Tonic 205

Hospices Civils de LyonOriginal source
🇫🇷Researchpresse.inserm.frTier 2 · Direct publisher

Using fewer cosmetics quickly reduce exposure to certain chemical pollutants and endocrine disruptors, such as bisphenol A

INSERMOriginal source
🌍Mediarhoworld.comTier 2 · Direct publisher

Parkinson’s Disease Trial Readiness Diagnostic

RhoOriginal source
🇨🇦Researchgenomecanada.caTier 2 · Direct publisher

Canada’s hardest problems demand a different kind of science. Here’s how we work.

Genome CanadaOriginal source
🇫🇷Researchchu-lyon.frTier 2 · Direct publisher

Hub Prévention cardiovasculaire et métabolique : et si vous deveniez acteur de votre santé ?

Hospices Civils de LyonOriginal source
🌍Researchunityhealth.toTier 2 · Direct publisher

Gift of Life: St. Michael’s Hospital hits significant milestone with 50 living kidney transplants in one year

St. Michael's Hospital (Toronto)Original source
🇺🇰Researchuclh.nhs.ukTier 2 · Direct publisher

Groundbreaking bowel cancer trial follow-up shows zero relapses

University College London Hospitals (UCLH)Original source
🇫🇮Researchhelsinki.fiTier 2 · Direct publisher

“Ilman pölyttäjiä maailma olisi ankea ja väritön” – Uusi näyttely avaa oven pölyttäjien kiehtovaan elämään

Helsinki University ResearchOriginal source
🌍Industrycibeles.com.uyTier 1 · Company source

TEMPO 420 SC

Cibeles (Uruguay)Original source
🌍Industrycibeles.com.uyTier 1 · Company source

TEMPO 420 SC

Cibeles (Uruguay)Original source
🇯🇵pharma_equipmentprodcms.ulvac.co.jpTier 2 · Direct publisher

USA-Japan Semiconductor Packaging Consortium "US‑JOINT" Begins Operations in Silicon Valley

Ulvac (Pharma)Original source
🌍CROcrucialdatasolutions.comTier 2 · Direct publisher

Where Study Simulation Fits in Clinical Trials

TrialKitOriginal source
🇯🇵CROen.cmicgroup.comTier 2 · Direct publisher

Outsourcing in Clinical Trials (OCT) UK & Ireland 2026

CMIC Group JapanOriginal source
🇺🇰CDMOergomedgroup.comTier 2 · Direct publisher

Ergomed Clinical Research Named Finalist in Fierce Outsourcing Awards 2026 for “Clinical Trial Management”

ErgomedOriginal source
🌍Researchunityhealth.toTier 2 · Direct publisher

Unity Health Toronto strengthens coordinated care for patients with high-risk pregnancies

St. Michael's Hospital (Toronto)Original source
🌍CROtrinetx.comTier 2 · Direct publisher

What Makes Real-World Evidence Credible? Insights from Academic Research

TriNetXOriginal source
🇯🇵pharma_equipmentprodcms.ulvac.co.jpTier 2 · Direct publisher

Joint Research | The University of Osaka Announcement: An advance in single-chip, energy-efficient circularly polarized LEDs

Ulvac (Pharma)Original source
🌍Industrymenicon.comTier 1 · Company source

Scleral lens “Time XL” acquires approval in China - New option for patients with irregular cornea available in the Chinese market -

MeniconOriginal source
🌍Industryrss.globenewswire.comTier 3 · Secondary coverage

GH Research Welcomes White House Executive Order to Accelerate Medical Treatments for Serious Mental Illness

GH ResearchOriginal source
🌍Industryenanta.comTier 1 · Company source

Zelicapavir Demonstrates High Clinical and Functional Barrier Against Antiviral Resistance: Results from a Randomized Double-Blind Placebo-Controlled Pediatric RSV Antiviral Clinical Trial

Enanta PharmaceuticalsOriginal source
🌍Industryenanta.comTier 1 · Company source

Zelicapavir Decreases Symptom Duration, Hospitalization and Viral Load in a Global, Randomized, Double-Blinded, Placebo-Controlled Phase II Trial of High-Risk Adults with RSV

Enanta PharmaceuticalsOriginal source
🇺🇸Devicesviz.aiTier 1 · Company source

Viz.ai Wins Gold Edison Award™ for Advancing AI-Driven Clinical Workflows to Improve Hemorrhage Care

Viz.aiOriginal source
🇺🇰Researchphar.cam.ac.ukTier 2 · Direct publisher

Pharmacology at the Cambridge Festival!

Cambridge Pharma ResearchOriginal source
🇩🇪Researchcharite.deTier 2 · Direct publisher

A fundamentally new therapeutic approach to cystic fibrosis: Nanobody repairs cellular defect

Charité - Universitätsmedizin Berlin (EN)Original source
🇯🇵Industrysanten.comTier 1 · Company source

Santen China Signs Exclusive Distribution and Promotion Agreement for Five Marketed Glaucoma Products in the Chinese Mainland

Santen PharmaceuticalOriginal source
🇺🇸Researchbroadinstitute.orgTier 2 · Direct publisher

Clinical trial of a prion disease drug candidate begins enrolling participants

Broad Institute NewsOriginal source
🇺🇸Industry4gclinical.comTier 1 · Company source

From “Must-Have” to Meaningful Progress: Creativity & Innovation Day

4G ClinicalOriginal source
🌍Industrysignanthealth.comTier 1 · Company source

Signant Health Enters Definitive Agreement to Acquire Ametris

Signant HealthOriginal source
🇺🇸CROcaidya.comTier 2 · Direct publisher

Ethics Review and Localization: Managing Multinational Approvals Effectively

Caidya (Clinipace)Original source
🌍Industrynimbustx.comTier 1 · Company source

Nimbus Therapeutics Presents New Mechanistic Data Highlighting Differentiated Biology of Selective SIK2 Inhibitors at IMMUNOLOGY2026™

Nimbus TherapeuticsOriginal source
🇨🇭CDMOsiegfried.chTier 2 · Direct publisher

Siegfried shareholders approve all proposals at Annual General Meeting 2026

SiegfriedOriginal source
🇫🇮Devicesaiforia.comTier 1 · Company source

Aiforia has been selected as an AI partner for the PROSTIA project - expands to five new hospitals in Paris

AiforiaOriginal source
🇸🇪CDMOrecipharm.comTier 2 · Direct publisher

CEPI awards seed funding to Analysis Zero to advance real-time RNA vaccine quality testing using NMR technology

Recipharm PressOriginal source
🇯🇵Devicessysmex.co.jpTier 1 · Company source

Educational Initiatives for the Next Generation - Implementing Health Education for Elementary School Students and SDGs Education for Junior and Senior High School Students -

Sysmex (Global)Original source
🇯🇵CROen.cmicgroup.comTier 2 · Direct publisher

Announcement of Launch in Japan of RAVICTI® Oral Liquid 1.1 g/mL

CMIC Group JapanOriginal source
🇺🇸Researchbroadinstitute.orgTier 2 · Direct publisher

Massive ancient-DNA study reveals natural selection has accelerated in recent human evolution

Broad Institute NewsOriginal source
🇮🇱Industryir.tevapharm.comTier 1 · Company source

Teva Launches Home Ground™ Schizophrenia Community, a New Online Resource Hub for People Living with Schizophrenia and Their Care Partners

Teva Pharmaceuticals RSSOriginal source
🌍Industryalloytx.comTier 1 · Company source

Alloy Therapeutics Announces $40M Series E to Scale Tech-Enabled Biotech Infrastructure

Alloy TherapeuticsOriginal source
🇺🇸Researchmdanderson.orgTier 2 · Direct publisher

Advances in translational cancer research

MD Anderson Cancer CenterOriginal source
🌍Industryrss.globenewswire.comTier 3 · Secondary coverage

neffy® (epinephrine nasal spray) Approved in Canada as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis)

ARS PharmaceuticalsOriginal source
🇺🇸Researchbroadinstitute.orgTier 2 · Direct publisher

Cancer Dependency Map Consortium launches Phase 3 to accelerate next-generation therapeutics

Broad Institute NewsOriginal source
🇺🇸Researchbroadinstitute.orgTier 2 · Direct publisher

Base editing repairs mutation and liver function in mouse model of Zellweger spectrum disorder

Broad Institute NewsOriginal source
🇮🇱Industryir.tevapharm.comTier 1 · Company source

Community Routes: Access to Mental Health Care Provides Continued Funding for Mental Health Services at Free & Charitable Clinics

Teva Pharmaceuticals RSSOriginal source
🇩🇪Mediadzne.deTier 2 · Direct publisher

A Concert Tour for the Science Year “Medicine of the Future”

DZNE (Neurodegenerative Diseases)Original source
🌍CROcrucialdatasolutions.comTier 2 · Direct publisher

How To Improve Patient Engagement in Clinical Trials

TrialKitOriginal source
🇯🇵CROen.cmicgroup.comTier 2 · Direct publisher

BIO International Convention 2026

CMIC Group JapanOriginal source
🇺🇰Researchphar.cam.ac.ukTier 2 · Direct publisher

Marking the 2026 Pharmacology-Industry Engagement Day

Cambridge Pharma ResearchOriginal source
🇪🇺Regulatoryvaccineseurope.euTier 1 · Regulatory source

EFPIA and Vaccines Europe response to the consultation on the EU Global Health Resilience Initiative

Vaccines EuropeOriginal source
🇺🇸Industryclinicalink.comTier 1 · Company source

Clinical ink announces Kaitality™, a first-in-class digital tool for improving drug adherence and measuring functional quality of weight loss

Clinical InkOriginal source